DACTINOMYCIN
2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
Molecular Identity
DACTINOMYCIN
2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
PubChem CID: 457193
Actinomycin D can cause cancer and developmental toxicity according to state or federal government labeling requirements.
2D Structure
Properties
C62H86N12O16
Molecular Formula
1255.40
Molecular Weight
g/mol
1254.6285
Exact Mass
Da
3.8
XLogP
Drug-like (Lipinski: < 5)
356
TPSA
May have limited oral absorption
5
H-Bond Donors
18
H-Bond Acceptors
3030
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
DACTINOMYCINactinomycin DActinomycin C1CosmegenActinomycin IVMeractinomycin50-76-0Actinomycin I1Actinomycin X1DactinomicinaDactinomycineDactinomycinumCosmegen LyovacLyovac-CosmegenOncostatin K
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to DACTINOMYCIN
Loading drug network...